Advertisement

Topics

Companies Related to "Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus" [Most Relevant Company Matches] RSS

14:50 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus" found in our extensive corporate database of over 50,000 company records.

Showing "Medroxyprogesterone Treating Patients With Endometrioid Adenocarcinoma Uterine Corpus" Companies 1–25 of 3,900+

Relevant

Acessa Health, Inc.

Acessa Health is a women’s health innovator dedicated to advancing minimally invasive, uterine-sparing solutions for women with symptomatic fibroids. The company introduced the use of radiofrequency ablation for the treatment of uterine fibroids and is continuing to develop technologies that improve the lives of its patients. Acessa Health’s head...


Avant Diagnostics, Inc.

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in large panel biomarker screening. Our first test, OvaDx®, developed in conjunction with Arrayit Corporation (OTCQB: ARYC), detects for pre-symptomatic ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system i...

Acessa Health Inc.

The Acessa System is the only radiofrequency ablation system cleared by the U.S. Food and Drug Administration and CE marked for use in percutaneous, laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. It has been the subject of 20 peer-reviewed publications across...


Gynesonics, Inc.

Gynesonics is a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids. Gynesonics has developed the VizAblate® System, a transcervical, ultrasound-guided ablation system for the treatment of uterine fibroids. VizAblate® has the CE Mark in the European Union and is currently limited to investigational...

BioSphere Medical, Inc.

BioSphere Medical, Inc. seeks to pioneer and commercialize minimally invasive diagnostic and therapeutic applications based on proprietary bioengineered microsphere technology. The Company’s core technologies, patented bioengineered polymers and manufacturing methods, are used to produce microscopic spherical materials with unique beneficial propertie...

NeuroPace, Inc.

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. Patients are currently being enrolled in a clinical trial of the company's Responsive N...

CerebralRx

Based in Yehud, Israel, CerebralRx was founded in 2010 as a spin-off of BioControl Medical to develop breakthrough implantable neuromodulation systems for the treatment of autonomic nervous system-related neurological disorders. The company’s flagship product is the FitNeS system, an implantable vagus nerve stimulation device for treating patients wit...

BioSphere Medical

Since 1999, BioSphere Medical's primary mission has been to be a global leader in embolotherapy. The Company is pioneering the use of patented bioengineered microspheres as a new class of embolics for the treatment of tumors and vascular malformations by occluding their blood supply. We are driving demand for our proprietary microsphere technology as we penetrate additional key markets and launch ...

ADD dental facility

Dr Nick Mohindra first became interested in this field when he was treating patients who were suffering from what is known as TMD syndrome. This is a group of symptoms including sore facial muscles, tense neck and shoulders, or back and head pains, often caused by jaw relationship problems. It occurred to him that the technique he was using to treat these patients could also benefit denture patien...

CryoPen, Inc.

CryoPen, Inc. is a leading cryosurgery innovator: designing, developing, marketing, and selling its CryoPen® Cryosurgical System and CryoPen® GY2 Cervical Attachment to primary care physicians, gynecologists, dermatologists, internists, pediatricians, and podiatrists. CryoPen, Inc. offers the most advanced, state of the art technology in the field of...

Sinexus, Inc.

Sinexus, Inc. (http://www.sinexusinc.com) is a development-stage medical device company that is pioneering novel therapies for Ear, Nose & Throat (ENT) physicians to utilize in providing improved treatment for their patients. Sinexus' initial focus is treating patients with Chronic Rhinosinusitis, a debilitating chronic condition that affects one out of seven adults in the United States.

Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...

Neural Intervention Technologies, Inc.

Neural Intervention Technologies (NIT) is a development stage medical device company focused on improving the quality of life of patients with blood vessel defects, including those of the brain that result in hemorrhagic stroke.NIT is developing ALGEL™-I and -II, novel embolic materials, into minimally invasive treatments for cerebral arteriovenous malformations and aneurysms. In addition, NIT w...

Diagnovus, LLC

Founded in 2011 and based in Nashville, Tenn., Diagnovus is a specialized molecular diagnostic company focused on delivering personalized information and services to physicians treating patients suffering from underserved, aggressive and lesser-known diseases. Its mission is to improve the health of patients and the quality of treatment decisions through e...

Shanghai Fulland Chemicals Ltd.

Fulland currently has four manufacturing facilities in Zhejiang, Hunan, and Jiangxi province China, mainly focusing on developing and producing API and intermediates of Steroids, oncology. For some APIs and intermediates of Steroids, we are the largest producer in China, and important provider in the global market. We especially hold excellent technology, specially facilities and plenty of produci...

SolaranRx, Inc.

SolaranRx, Inc. is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for treating metastatic melanoma. SolaranRx seeks to improve treatment and patientsâ€...

SolaranRx

SolaranRx, Inc. is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for treating advanced melanoma. SolaranRx seeks to improve treatment and patients’...

ViroLogic

ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to make rational treatment decisions in the management of viral diseases. The company's proprietary technology is also being used in the fields of viral pharmacogenomics to identify, analyze, and select n...

Probably Relevant

SetPoint Medical

SetPoint Medical is a privately held biomedical technology company dedicated to treating patients with debilitating inflammatory diseases using proprietary implantable neuromodulation devices.

VisCardia Inc

VisCardia based in Portland, OR is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe. To learn more about VisCardia, visit: http://www.viscardia.com

VisCardia Inc.

VisCardia, based in Portland, OR, is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe. To learn more about VisCardia, visit: http://www.viscardia.com.

Cancer Vaccines Ltd

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1999 and won a DTI SMART Award.The attraction of a vaccination based approach to treating cancer is widely acknowledged, and many researchers and clinicians have worked in this area. Historically the a...

AEGEA Medical Inc.

AEGEA Medical is a private, clinical-stage medical device company that is developing a novel treatment for abnormal uterine bleeding. The company’s products are not available for sale in the United States. www.aegeamedical.com

Pacific Sleep Medicine Services, Inc

Pacific Sleep Medicine Services offers individual consultations and diagnostic evaluations for patients suspected of sleep disorders. All of our physicians are board certified sleep specialists, dedicated to identifying and providing treatment recommendations for sleep disorders by working with patients and their referring physicians in treating sleep disorders.

NewLink Genetics

NewLink Genetics is a private biopharmaceutical company with innovative technologies that are powering a late stage pipeline targeted at tough to treat cancers and infectious disease. NewLink's two complementary technology platforms target separate mechanisms that are commonly utilized by different cancer types to avoid immune system detection and destruction. The company's HyperAcute® cancer imm...


More From BioPortfolio on "Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks